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Endothelial sprouting and proliferation are tightly coordinated processes mediating the formation of new blood vessels during physiological and pathological angiogenesis. Endothelial tip cells lead sprouts and are thought to suppress tip-like behaviour in adjacent stalk endothelial cells by activating Notch. Here, we show with genetic experiments in postnatal mice that the level of active Notch signalling is more important than the direct Dll4-mediated cell-cell communication between endothelial cells. We identify endothelial expression of VEGF-A and of the chemokine receptor CXCR4 as key processes controlling Notch-dependent vessel growth. Surprisingly, genetic experiments targeting endothelial tip cells in vivo reveal that they retain their function without Dll4 and are also not replaced by adjacent, Dll4-positive cells. Instead, activation of Notch directs tip-derived endothelial cells into developing arteries and thereby establishes that Dll4-Notch signalling couples sprouting angiogenesis and artery formation.
Angiogenesis is essential during development and regeneration but is also involved in pathological processes such as cancer. Endothelial cell (EC) sprouting and proliferation, which mediate the extension of vascular networks, are induced by tissue-derived vascular endothelial growth factor A (VEGF-A) and its endothelial receptor VEGFR2, also known as Flk1 or KDR 1, 2 . Notch signalling interactions between adjacent ECs are thought to coordinate the cooperative behaviour of cells during sprouting angiogenesis. VEGFR2 activity upregulates expression of the Notch ligand Delta-like 4 (Dll4) in filopodiaextending tip cells at the distal end of sprouts [3] [4] [5] . In turn, Dll4-mediated activation of Notch suppresses tip cell behaviour in trailing stalk ECs, which form the base of sprouts 3, 4, [6] [7] [8] . Accordingly, inhibition of Dll4-Notch interactions results in excessive sprouting and EC hyperproliferation 3, 4, 6, [8] [9] [10] . Dll4-Notch signalling is opposed by the ligand Jagged1, which is pro-angiogenic and predominantly expressed by stalk and capillary ECs [11] [12] [13] . The behaviour of sprouting ECs is thought to be highly dynamic, enabling rapid replacement of tip cells and switching between tip/stalk phenotypes 7, 14 . Mathematical models have proposed feedback loops involving VEGF-induced Dll4 expression in tip cells and Notchmediated suppression of VEGFR2 expression in stalk ECs 7, [15] [16] [17] [18] . Nevertheless, the processes occurring downstream of Notch and the regulation of endothelial sprouting have remained insufficiently understood. Here, we have used genetic and pharmacological approaches in mice to unravel the cooperation between different signalling pathways. Moreover, genetic tools allowing the selective manipulation of tip cells establish that Dll4-Notch signalling induces an endothelial fate switch and specifies future arterial ECs among the tip cell progeny at the angiogenic growth front.
RESULTS

Notch-dependent expression of angiogenic regulators
Consistent with previous reports 4, 5, 8 , EC-specific inactivation of the Dll4 gene in mice (Dll4 i EC/ EC ) at postnatal day 6 (P6) led to a dramatic increase in retinal vessel density with an accompanying loss of arteriovenous patterning (Fig. 1a,b ). This phenotype was not enhanced by the simultaneous inactivation of Dll1, the gene encoding Delta-like 1, a Notch ligand with limited expression in ECs 19, 20 ( Supplementary Fig. 1a,b ). Arguing that a sufficient threshold of Notch activation is more critical than the actual Dll4-mediated communication between ECs, Cre-dependent expression of active Notch1 intracellular domain (NICD iOEC ) was sufficient to i EC/ EC whole retina samples (n = 8 control and 7 Dll4 i EC/ EC mice). Data represent mean ± s.e.m. P values, two-tailed unpaired t-test. NS, not significant.
restore Notch target gene expression in freshly isolated Dll4 i EC/ EC retinal ECs and rescued defects seen in the Dll4 i EC/ EC retinal vasculature (Fig. 1a,b and Supplementary Fig. 1c-g ). The area covered by Dll4 i EC/ EC NICD iOEC/+ or Dll4 i EC/ EC NICD iOEC/OEC vessels was reduced close to control levels and vascular outgrowth was restored. The number of branch points, uncountable in Dll4 i EC/ EC mutants, was normalized in Dll4 i EC/ EC NICD iOEC/OEC retinas, and arteries and veins were clearly detectable (Fig. 1a,b and Supplementary Fig. 1c ).
To explain how downstream effectors might influence the NICDdependent rescue of the Dll4 loss-of-function phenotype, we investigated two known important regulators of EC behaviour, namely CXCR4 and endothelial VEGF-A. CXCR4, the receptor for the chemokine CXCL12, also known as SDF1, provides directional cues for growing blood and lymphatic vessels [21] [22] [23] [24] [25] . Consistent with published data on tip-cell-enriched genes 24 , CXCR4 immunostaining decorated endothelial sprouts in P6 retinas (Fig. 1c) . CXCR4 protein and Cxcr4 mRNA levels were upregulated in the Dll4 i EC/ EC vasculature, whereas CXCR4 immunostaining was substantially reduced in Dll4 i EC/ EC NICD iOEC/+ or Dll4 i EC/ EC NICD iOEC/OEC compound mutants (Fig. 1c,d ). VEGF-A is expressed by hypoxic cells resulting in paracrine activation of ECs 26, 27 , but the growth factor is also produced by ECs to control survival and angiogenesis in a presumably autocrine fashion [28] [29] [30] . Vegfa transcripts were significantly increased in freshly isolated Dll4 i EC/ EC retinal ECs and strong VEGF-A immunostaining was seen within the hypertrophic mutant vessels (Fig. 1c-e and Supplementary Fig. 1d ). Endothelial VEGF-A staining was no longer detectable after NICD-mediated rescue of the Dll4 i EC/ EC phenotype, which also reduced VEGF-A expression in the avascular retina ( Fig. 1c and Supplementary Fig. 1d ). VEGF-A immunosignals were, however, occasionally seen in dense endothelial foci of Dll4 i EC/ EC NICD iOEC/OEC compound mutants, which are likely to reflect small areas of insufficient rescue ( Supplementary Fig. 1e ). Indicating that the levels of endothelial Notch activation were not excessively high, transcript levels of the Notch target genes Hes1, Hey1 and Efnb2 were close to control in ECs from NICD iOEC/OEC homozygotes and, unexpectedly, elevated about twofold in NICD iOEC/+ heterozygotes ( Supplementary Fig. 1f ).
Consistent with the observed regulation of endothelial VEGF-A by Notch, expression of ESM1, a tip cell marker and VEGF-regulated gene product 31, 32 , was upregulated in Dll4 i EC/ EC retinal vessels ( Fig. 1d  and Supplementary Fig. 1g ). Upregulation of Esm1 and specific Vegfa isoforms was also detectable in whole retina lysates (Fig. 1e) . As for CXCR4, ESM1 immunostaining was strongly reduced after NICDmediated rescue of Dll4 i EC/ EC mutants, which failed to fully restore the tip-cell-restricted pattern of ESM1 distribution ( Supplementary  Fig. 1g ). Together, these data identify endothelial VEGF-A and CXCR4 as potential Notch-dependent regulators of angiogenesis. Overlapping CXCR4 and VEGF-A immunostaining in the angiogenic front suggests that the two pathways might be linked (Supplementary Fig. 2f ).
VEGF-A and CXCR4 in Notch-controlled angiogenesis
To address the role of endothelial VEGF-A, we generated EC-specific and inducible Vegfa i EC/ EC mutants. Consistent with previous reports on endothelial VEGF-A expression [28] [29] [30] , loss of a single or both Vegfa alleles in ECs led to substantially reduced vessel growth and branching (Fig. 2a,b and Supplementary Fig. 2a-c) . Pharmacological inhibition of Notch by administration of the γ-secretase inhibitor DAPT led to increased EC density and sprouting in proximity of the avascular region expressing VEGF-A, but had little effect in the Vegfa i EC/+ or Vegfa i EC/ EC central retina (Fig. 2a-c and Supplementary Fig. 2a-c) . Consistent with these regional differences, VEGF-A immunostaining was readily detectable in the avascular retinal tissue but not within the DAPT-treated Vefga i EC/ EC vasculature (Fig. 2d) . Likewise, increases in Dll4 and ESM1 immunostaining were pronounced in DAPT-treated controls but diminished in Vefga i EC/ EC retinas ( Fig. 2e and Supplementary Fig. 2e ). These data argue that Notch-dependent regulation of endothelial VEGF-A plays a key role in the control of EC behaviour.
CXCR4 expression in the P6 wild-type retina was detected in tip cells, in some ECs of the vessel plexus, in arterial ECs and outside the vasculature, while the ligand CXCL12 was expressed by astrocytes in proximity of endothelial sprouts and by perivascular cells (Fig. 3a,b) . Inducible and EC-specific inactivation of the Cxcr4 gene led to reduced vessel outgrowth, density and branching, and impaired EC proliferation and sprouting in the P6 Cxcr4 i EC/ EC retinal vasculature (Fig. 3c,d and Supplementary Fig. 3a ,b,e). A similar phenotype was obtained in Cxcr4 i EC/KO mice carrying one constitutive and one conditional knockout allele ( Fig. 3e and Supplementary Fig. 3a,c,f) . Immunostaining of the tip cell marker ESM1 was unchanged in Cxcr4 loss-of-function mutants despite increased VEGF-A expression in the avascular retina ( Fig. 3f and Supplementary Fig. 3d ). Analysis of freshly isolated Cxcr4 i EC/ EC retinal ECs showed no change in Esm1 transcript expression, whereas Vegfa was slightly but not statistically significantly increased (Supplementary Fig. 3g ). CXCR4 does not appear to act upstream of Notch, as transcripts for Dll4, Jag1 and the Notch targets Hey1 and Hes1 were not significantly changed in isolated Cxcr4 i EC/ EC retinal ECs ( Supplementary Fig. 3h ). Consistent with the upregulation of CXCR4 in Dll4 i EC/ EC retinal ECs (Fig. 1c,d) , loss of the chemokine receptor led to reduced sprouting after Notch inhibition (Fig. 4a,b and Supplementary Fig. 4a,b ) despite strong upregulation of VEGF-A at the vascular growth front (Fig. 3f) . Acute pharmacological inhibition of CXCL12-CXCR4 signalling with AMD3100 led to significantly reduced sprouting and a blunt appearance of the distal Dll4 i EC/ EC vessel plexus (Fig. 4c,d and Supplementary Fig. 4c ). Likewise, genetic approaches combining ECspecific mutant alleles of Cxcr4 and Rbpj, the essential downstream mediator of Notch-induced gene transcription 33 , led to significant reductions in vessel outgrowth, EC-covered area and sprouting relative to control littermates (Fig. 4e,f and Supplementary Fig. 4d,e) . Impaired sprouting, visible as a blunt angiogenic growth front, was also seen in Cxcr4 i EC/ EC Dll4 i EC/ EC double mutants ( Supplementary Fig. 4f,g ).
Investigation of Notch and VEGF-A-mediated processes
Next, we investigated whether Notch signalling and the transcription factor RBPJ directly regulate expression of Cxcr4, Vegfa and Esm1 in ECs. Chromatin immunoprecipitation (ChIP) in the murine endothelial cell line MS1 showed strong RBPJ binding to the Vegfa locus and the positive control Hes1, whereas RBPJ occupancy to putative binding sites was weak for Cxcr4 and absent for Esm1 ( Fig. 5a and Supplementary Fig. 5b ). DAPT treatment downregulated expression of the Notch target genes Hes1, Dll4 and Nrarp indicating active Notch signalling in MS1 cells ( Supplementary Fig. 5c ). Active histone modification, namely H3K27ac, H3K4me1, H3K4me3 and H3K9ac, but not the repressive marks H3K9me3 and H3K27me3, were enriched at the RBPJ-binding site in Hes1 (Fig. 5b,c and Supplementary Fig. 5a ,b). In contrast, Cxcr4, Vegfa and Esm1 were only marginally altered by DAPT treatment in MS1 cells. Both active and repressive histone marks were found at RBPJ-bound sites of Cxcr4, Vegfa and Esm1, suggesting a poised state (Fig. 5b,c and Supplementary Fig. 5a -c).
These data are consistent with a potential direct negative regulation of Vegfa expression by RBPJ in ECs similar to what has been previously described for adult cardiomyocytes 34 . Accordingly, VEGF-A immunosignals were strongly upregulated in Rbpj i EC/ EC retinal ECs in vivo (Supplementary Fig. 5d ).
Outside the endothelium, VEGF-A was upregulated in the peripheral avascular tissue in Cxcr4 i EC/KO (Fig. 3f ) and Dll4 i EC/ EC (Fig. 1c,d ) retinas as well as in NICD iOEC/OEC samples ( Supplementary  Fig. 5g ,h,n). Isolated NICD iOEC/OEC retinal ECs showed significantly increased transcript levels for Dll4, a known Notch target gene, but also for Vegfa and Esm1 (Supplementary Fig. 5e ). Endothelial Cxcr4 transcripts were also increased, which was, however, not reflected in immunostainings ( Fig. 5d and Supplementary Fig. 5e,i) . Next, we investigated the contribution of VEGF-A/VEGFR2 in the regulation of CXCR4 and ESM1. Notch activation has been linked to reduced VEGFR2 expression 6, [35] [36] [37] [38] . Our previous work argued that Notch inhibition triggers retinal angiogenesis after genetic or pharmacological interference with VEGFR2 (ref. 8) , while another study attributed such effects to residual VEGFR2 activity 5 . A stringent genetic strategy combining conditional and constitutive knockout alleles of murine Flk1 led to highly diminished expression of VEGFR2, which strongly impaired vascular growth in the resulting Flk1 i EC/KO mutants ( Fig. 5e and Supplementary Fig. 5j ). This was accompanied by strong upregulation of VEGF-A immunostaining and Vegfa transcripts but reduced expression of ESM1, Dll4 and CXCR4 at the angiogenic front (Fig. 5f,g and Supplementary Fig. 5f ,j,k). Global levels of Cxcr4 and Dll4 transcripts were slightly but significantly reduced in freshly sorted Flk1 i EC/KO retinal ECs (Supplementary Fig. 5f ). Consistent with the role of VEGF-A/VEGFR2 interactions as a survival signal, EC death was profoundly increased in the Flk1 i EC/KO vasculature ( Supplementary Fig. 5l ). Despite the strong reduction in Flk1 i EC/KO retinal vessels, DAPT treatment led to focal EC proliferation both inside and at the peripheral edge of the vascular plexus (Fig. 5e ). These foci were positive for VEGF-A immunostaining ( Fig. 5f ) and might represent areas of residual signalling activity. ESM1 and CXCR4 were no longer upregulated in the DAPT-treated Flk1 i EC/KO retinal endothelium ( Fig. 5g and Supplementary Fig. 5m ). Furthermore, treatment with anti-VEGF-A blocking antibodies suppressed ESM1 and CXCR4 upregulation in NICD iOEC/OEC retinal ECs (Fig. 5d ). These data argue that enhanced EC proliferation and sprouting after Notch inhibition involve the upregulation of endothelial VEGF-A together with a VEGF-A/VEGFR2-dependent increase in CXCR4.
Genetic analysis of tip cell behaviour
While genetic experiments affecting all ECs have provided valuable insights into the regulation of angiogenesis, it remains difficult to assign phenotypic alterations specifically to tip cells, stalk cells or other ECs in vivo. Such limitations can be overcome by generating mosaic mutants or Cre transgenic strains targeting EC subsets 39, 40 . Here, we made use of Esm1-CreERT2 transgenic mice 32 , which mimic the tipcell-specific expression of ESM1 in retina 31 , in combination with the R26-mTmG T/+ Cre reporter 41 ( Fig. 6a,b and Supplementary Fig. 6a ). Following injection with a low dose of 4-hydroxytamoxifen (4-OHT), Esm1-CreERT2 transgenics enable irreversible genetic labelling and fate mapping of tip cells 42 ( Fig. 6a,b) . Analysis of retinas from P6 mice, which had received a single 4-OHT pulse at different time points prior to analysis, indicated that Esm1-CreERT2-labelled (GFP + ) ECs expand over time and populate the angiogenic growth front even after a 96 h chase period (Fig. 6b) . Similar experiments with the multicolour Cre reporter R26R-Confetti 43 established that this expansion of Esm1-CreERT2-labelled ECs is clonal ( Fig. 6c and Supplementary Fig. 6b ). As we have previously reported 42 , an increasing number of Esm1-CreERT2-labelled ECs was found inside the arterial but not venous endothelium (Fig. 6b) .
Next, we used the Esm1-CreERT2 strain to investigate CXCR4 function in tip cells. Cxcr4
i TC/KO mice were generated by combining a global knockout and a conditional, tip cell-specific mutant Cxcr4 allele in the R26-mTmG Cre reporter background. Compared with GFP + cells in Cxcr4 +/KO littermate controls, the overall number of labelled Cxcr4 i TC/KO ECs was not reduced, but mutant cells were significantly less abundant in vessel sprouts ( Fig. 6d and Supplementary Fig. 6c,d ). Those GFP + Cxcr4 i TC/KO cells located in sprouts were frequently excluded from the leading position, which was instead occupied by unrecombined (GFP − ) ECs (Fig. 6d) . Thus, loss of CXCR4 impairs the ability of retinal ECs to act as tip cells.
Regulation of retinal tip cell behaviour by the Notch pathway
Dll4 is a frequently used tip cell marker and is thought to suppress tip-like behaviour in adjacent stalk cells by activating Notch 4, 6, 9, 44 . We used Esm1-CreERT2-mediated inactivation of Notch1 in combination with the R26-mTmG Cre reporter to track the resulting GFP T/+ R26-mTmG T/+ retinal vasculature (IB4, blue). GFP expression appeared at 6 h after 4-OHT injection in some tip cells and labelled sprouts up to 96 h after injection (arrowheads). While some recombined cells appeared in arteries after 24 h, substantially more GFP + ECs were incorporated at 48 and 96 h (arrows). (c) Clonal expansion (encircled areas) of Esm1-CreERT2
T/+ R26R-Confetti i TC/ TC retinas) and of recombined GFP + sprouts per front area (n = 7 control and 6 Jag1 i TC/ TC retinas) at 96 h after 4-OHT injection. Jag1 i TC/ TC ECs were less abundant throughout the vasculature and in sprouts. Data represent mean ± s.e.m. P values, two-tailed unpaired t-test. (f) IB4 (blue), GFP (green) and Jag1 (white) staining of Jag1 i TC/ TC and control retinas at 96 h after 4-OHT injection. Note the Jag1 immunostaining in ECs at the control angiogenic front but lost or reduced signal in GFP + Jag1 i TC/ TC ECs (arrowheads).
angiogenic front after a single 4-OHT injection at 96 h prior to analysis (Fig. 6e,g and Supplementary Fig. 6e) . A similar approach for the analysis of Rbpj i TC/ TC ECs (see Methods) also led to enrichment of GFP-labelled mutant cells at the angiogenic front (Fig. 6f,h) (Fig. 6g,h ). Next, we tracked GFP + Dll4 i TC/ TC R26-mTmG ECs after Esm1-CreERT2-mediated inactivation of Dll4. GFP + Dll4 i TC/ TC ECs were enriched at P6 after a single 4-OHT injection and successful loss of Dll4 in GFP + ECs was validated by immunohistochemistry (Fig. 7a ,b and Supplementary Fig. 7a,b) . Dll4 i TC/ TC ECs were significantly enriched in sprouts indicating that there is no cell-autonomous requirement for Dll4 in tip cells (Fig. 7b) . Moreover, GFP + Dll4-deficient tip cells were frequently seen in direct proximity of unrecombined stalk cells exhibiting Dll4 immunostaining (Fig. 7c) . Esm1-CreERT2-mediated loss of Dll4 also led to the emergence of extensive protrusions in recombined ECs, which was most evident in Dll4 i TC/ TC mutants at 48 h after 4-OHT treatment (Supplementary Fig. 7a ). Similar to panendothelial Dll4 mutants, CXCR4 was upregulated in the Dll4 i TC/ TC vasculature, whereas immunostaining of Jagged1 was locally reduced ( Supplementary Fig. 7c,d ). When the role of Jagged1 was investigated with Esm1-CreERT2 transgenic mice, the abundance of Jag1-deficient cells within sprouts was significantly reduced at 96 h (Fig. 7d,e) . The loss of Jagged1 protein in GFP + ECs was confirmed by immunostaining (Fig. 7f ). CXCR4 and Dll4 immunostaining was comparable in Jag1 i TC/ TC and control retinas ( Supplementary Fig. 7e,f) . These results show that loss of Dll4 did not compromise the ability of ECs to function as tip cells, whereas the abundance of Jag1-deficient cells was reduced in sprouts.
Notch activation specifies pre-arterial, tip-cell-derived ECs
To investigate the effect of Notch activation (that is, NICD expression) in ESM1
+ tip cells, we combined Esm1-CreERT2 transgenic mice and Gt(ROSA)26Sor tm1(Notch1)Dam homozygotes (NICD iOTC/OTC ). Credependent NICD expression was detected by the presence of nuclearlocalized GFP encoded by the Gt(ROSA)26Sor tm1(Notch1)Dam allele 46 .
Analysis of the resulting mutants showed that GFP
ECs were abundant at the front and in capillaries at 24 or 48 h after 4-OHT administration, whereas GFP + cells were increasingly confined to arteries in both the central and peripheral retina after 72 and 96 h (Fig. 8a,b and Supplementary Fig. 8a ). GFP + NICD iOTC/OTC ECs expressed Dll4 and showed CXCR4 immunostaining ( Supplementary  Fig. 8a-c) . Further supporting an important role of Dll4-Notch signalling in the specification of arterial ECs at the angiogenic front, GFP + Dll4 i TC/ TC , Jag1 i TC/ TC , Notch1 i TC/ TC and Rbpj i TC/ TC ECs were significantly less abundant in arteries than control ECs, whereas arterial contribution was not significantly different between GFP + Cxcr4 i TC/KO mutant and Cxcr4 +/KO control ECs ( Fig. 8c and Supplementary Fig. 8d ).
An improved immunostaining protocol visualizing active (cleaved) Notch 47 showed the expected labelling of arteries, perivascular cells and a subset of ECs within endothelial sprouts ( Supplementary  Fig. 8e ). NICD-positive ECs were also found within the vascular plexus in proximity of small arterioles. For visualization of Notch signalling in tip-cell-derived ECs, we introduced the CBF:H2B-Venus 48 Notch reporter allele into Esm1-CreERT2 mice carrying the ROSA26-tdRFP T /+ Cre reporter 49 . H2B-Venus-positive and -negative endothelial nuclei (visualized by ERG immunostaining) indicated that ECs were not uniformly labelled due to longevity of the Notch reporter signal (Fig. 8d and Supplementary Fig. 8f ). H2B-Venus signal was seen in RFP + ERG + CXCR4 + tip cells at the angiogenic front and in tip-cell-derived ECs within the capillary plexus. While CXCR4 labelled the distal endothelial sprouts directed towards the avascular retina, this polarity was reversed within the plexus consistent with the migration of RFP + ERG + ECs towards arteries ( Fig. 8d and Supplementary Fig. 8f ). These data argue that Notch activation controls an important behavioural switch in tip-cell-derived ECs at the angiogenic front. Cells with high Notch activity are directed into developing arteries, whereas other tip cell progeny-presumably with a lower level of Notch signalling-continue to function as tip cells even in the absence of Dll4. These findings are consistent with the established role of Notch in arterial differentiation 9, [50] [51] [52] [53] .
DISCUSSION
Our results show that Notch inhibition triggers upregulation of endothelial VEGF-A and CXCR4, which enhances endothelial sprouting and proliferation. ChIP experiments indicate binding of RBPJ, which can act as a transcriptional activator or repressor 54, 55 , to Vegfa, which may regulate expression of the growth factor directly, whereas Cxcr4 expression appears to be controlled by VEGF-A/VEGFR2 signalling. Thus, endothelial VEGF-A is not only a survival signal 28 but also a critical regulator of vascular growth. Strikingly, EC-specific Vegfr2 mutants display very severe vascular defects 5, 8 and substantial EC apoptosis but still respond to Notch inhibition. As therapeutic VEGF-A/VEGFR2 inhibition is limited by factors such as compound efficiency, kinetics and side effects, the impact of low or impaired endothelial Notch signalling in this context deserves further investigation.
VEGF-A and Dll4-Notch signalling has been implicated in the specification of endothelial tip cells and in positional changes within sprouts 3, 4, 6, 7, 9, 14 . Esm1-CreERT2-mediated marking of tip cells indicates that labelled ECs and their progeny can retain their leading position in sprouts for prolonged time periods in vivo. It was also suggested, in critical parts relying on data obtained from in vitro assays, that Dll4 mediates competitive interactions between ECs striving for the tip position 7, 14 , whereas our results show that Dll4-deficient tip cells can lead sprouts and even gain a competitive advantage over unrecombined ECs in vivo. Thus, ESM1
+ tip cells appear intrinsically primed to mediate sprouting processes (Fig. 8e ). An independent study has made similar findings in the developing zebrafish embryo. Tip cells lacking dll4 can acquire and retain the leading position in vessel sprouts and also display substantial Notch activation, which was demonstrated by in vivo live imaging of transgenic reporter animals 56 . These findings are consistent with our conclusion that Dll4-Notch signaling interactions occur among the tip cell progeny to control the specification of future arterial ECs. In our model, ECs are primed by Notch activation at the angiogenic front, migrate into the vessel plexus and mediate artery growth (Fig. 8e) . This is consistent with our previous finding that Notch activity is not required within the postnatal arterial endothelium 39 , whereas pan-endothelial Notch pathway mutants exhibit profound arterial defects 4, 19, 39, 57, 58 . Arterial incorporation of former tip cells was also observed during zebrafish tail fin regeneration 42 . Vein-derived tip cells turn around and move into expanding arteries but not veins. This migration is collective and was rescued by wild-type cells in mosaic cxcr4a loss-of-function mutants. Cooperative behaviour may also explain why retinal Cxcr4 i TC/KO ECs had an impaired ability to lead sprouts, whereas arterial incorporation was not significantly altered. On the basis of the evidence presented here, we propose that signalling processes in angiogenic sprouts are directly coupled to artery formation (Fig. 8e) , which might coordinate vessel growth and arterial network enlargement.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper. , Esm1-CreERT2 T/+ transgenics were combined with R26-mTmG T/T Cre reporter mice 41 . The generated offspring were injected with 12.5 µg of 4-hydroxytamoxifen (4-OHT) (Sigma, H7904) at time points described in the text and legends and analysed at P6. For clonal expansion analysis, Esm1-CreERT2
T/+ transgenics were combined with R26R-Confetti T/+ reporter mice 43 . The resulting pups were injected with 50 µg tamoxifen at P1 and P2 and analysed at P6.
To inactivate Cxcr4 in tip cells, Esm1-CreERT2 T/+ Cxcr4 +/KO and Cxcr4 lox/+ R26-mTmG T/T mice were interbred. The resulting offspring were injected once at P2 with 12.5 µg of 4-OHT and Cre + mice were analysed at P6.
To inactivate Dll4, Jag1 For CXCR4 inhibition, AMD3100 (Sigma, A5602; 40 µg g −1 body weight) was administered twice to Dll4 i EC/ EC pups at P5, 12 h and 24 h after 50 µg tamoxifen injection at P4. Pups were analysed at P6, 36 h after tamoxifen treatment.
For VEGF-A inhibition, NICD iOEC/OEC and control littermates were injected with tamoxifen from P1 to P3 and with anti-mouse VEGF-A antibody (Bayer, clone G6-23; 1.42 mg ml −1 , 35 mg kg −1 body weight) or a similar volume of PBS at P4 and P5. Pups were analysed at P6, 48 h after the first antibody injection.
All animal experiments were performed in compliance with the relevant laws and institutional guidelines, were approved by local animal ethics committees and were conducted at the University of Münster and the MPI for Molecular Biomedicine with permissions granted by the Landesamt für Natur, Umwelt und Verbraucherschutz (LANUV) of North Rhine-Westphalia. Animals were combined in groups for experiments irrespective of their sex.
Whole-mount immunohistochemistry of mouse retinas. Retina immunostaining was performed according to a previously published protocol 61 with minor modifications. Eyes were enucleated and fixed in 4% PFA in PBS. Dissected retinas were blocked in block buffer (1% BSA, 0.3% Triton X-100 in PBS) for 30 min at room temperature and rinsed twice with modified Pblec buffer (1 mM CaCl 2 , 1 mM MgCl 2 , 1 mM MnCl 2 , 0.4% Triton X-100 in PBS). Retinas were incubated overnight at 4 • C with isolectin B4 (IB4) and primary antibodies (see Supplementary  Table 1 ) diluted in modified Pblec buffer. The next day, retinas were washed once in block buffer diluted 1:1 with PBS and three times in PBS. Retinas were incubated with Alexa Fluor (AF)-coupled species-specific secondary antibody (Supplementary Table 1 ) diluted in block buffer for 1.5 h at room temperature. Retinas were further washed as described above and flat-mounted on glass slides using Fluoromount-G (Southern Biotech, 0100-01).
Immunostaining of Esm1-CreERT2 T/+ CBF:H2B-Venus T/+ ROSA26-tdRFP T/+ retinas was performed as described above, with some modifications. After the block/permeabilization step, retinas were incubated overnight at 4 • C with rabbit anti-RFP antibody (Supplementary Table 1 ). The next day, retinas were washed and incubated with AF-546-coupled donkey anti-rabbit secondary antibody diluted in block buffer for 1.5 h at room temperature. Retinas were further washed and incubated for 1.5 h at room temperature with donkey anti-rabbit F(ab)2 fragments (Supplementary Table 1 ) to prevent excessive cross-talk with the following primary rabbit antibody. After washing, retinas were re-blocked as before and incubated with IB4, chicken anti-GFP, rabbit anti-ERG and rat anti-CXCR4 antibodies overnight at 4 • C. The next day, retinas were washed and incubated with appropriate secondary antibodies (streptavidin-AF-405, donkey anti-chicken-AF-488, donkey anti-rabbit-AF-594 and donkey anti-rat-AF-647) for 1.5 h at room temperature and processed as described above. All images shown in the figures are representative for the respective staining in at least three mice unless stated otherwise.
Antigen retrieval for detection of active NICD in mouse retina. Detection of endogenous active NOTCH1 was performed using the antigen retrieval method described in ref. 47 . C57BL/6J eyes were fixed for 30 min at room temperature in 4% PFA in PBS. Sodium citrate solution (10 mM; pH 6.0) was brought to boiling in a plastic container in a microwave oven and dissected retinas were boiled for 15 min (800 W). Alternatively, retinas were incubated for 15 min in 2 ml Eppendorf tubes filled with sodium citrate solution and placed in a water bath at 95 • C. After cooling down for 20-30 min, retinas were washed four times with distilled water and once with PBS, 3 min per washing step. Endogenous peroxidase was quenched with 'killing solution' (1% H 2 O 2 in 100% methanol) by incubating retinas for 40 min at room temperature. After three PBS washes for 5 min each, retinas were permeabilized twice in 0.3% Triton X-100/PBS for 10 min each. Retinas were then blocked in Histoblock solution (3% BSA, 20 mM MgCl 2 , 0.3% Triton X-100, 5% goat serum in PBS) for 1 h at room temperature. Retinas were incubated overnight with primary IB4-488-Alexa Fluor-coupled and rabbit anti-cleaved Notch1 Val1744 antibody (Supplementary Table 1 ) diluted in Histoblock solution. The next day, retinas were washed twice in PBS and in 0.3% Triton X-100/PBS, 5 min per washing step. Retinas were incubated with goat anti-rabbit biotinylated secondary antibody diluted in 5% BSA in PBS for 1 h at room temperature. Subsequently, retinas were washed as before and incubated with ABC solution (Vector, PK-6100) for 1 h at room temperature. Next, retinas were washed twice for 5 min with 0.3% Triton X-100/PBS and were incubated for 5 min at room temperature with freshly prepared TSA-Cy3 working solution (Perkin Elmer, NEL744001KT). After two washes with PBS and 0.3% Triton X-100/PBS retinas were mounted as described before.
In vivo EdU labelling and detection. To analyse EC proliferation, pups were injected intraperitoneally with 50 µl EdU nucleotides (2 mg ml −1 in PBS) at P6, 2 h before euthanization. To detect EdU incorporation in retina vasculature Click-iT EdU Imaging Kit was used (Thermo Fisher Scientific, C10340).
FACS sorting of mouse retinal ECs.
Collagenase solution (200 U ml −1 ) was prepared in DMEM (Gibco, 31053028) from a 10× stock solution containing 1:1:1 mixture of collagenase I (Gibco, 170100-017), collagenase II (Gibco, 17101-015) and collagenase IV (Gibco, 17104-019). Retinas were dissected from freshly collected eyes and digested in collagenase solution by incubation at 37 • C for 40 min. Lysates were transferred on ice and homogenized by pipetting and vortexing. Digested tissue was filtered through a 70 µm cell strainer (Falcon, 352350) and resuspended in DMEM with 10% FCS. Tissue was spun down in a refrigerated centrifuge for 5 min at 300g . The pellet was resuspended in antibody solution (Supplementary Table 1 ) prepared in DMEM with 3% FCS. Cells were stained for 30 min on ice and then washed twice with DMEM containing 3% FCS. Retinal cells were resuspended in DMEM with 3% FCS and treated with DAPI to exclude dead cells. CD31 + /CD45 − cells were sorted using a FACS Canto flow cytometer and analysed using FACSDiva software (BD Bioscience, Version 6.0).
RNA extraction from isolated retinal ECs and RT-qPCR.
Retinal ECs were sorted in RLT Plus lysis buffer (Qiagen, 1053393) supplemented with β-mercaptoethanol. RNA extraction was performed using RNeasy Plus Micro Kit (Qiagen, 74034). Whole RNA was reverse transcribed and converted to cDNA using the iScript cDNA synthesis kit (Bio-Rad, 170-8890). Taqman primers, FAM-conjugated probes for Cxcr4, Dll4, Esm1, Hes1, Hey1, Jag1, Nrarp, Vegfa and Vegfr2 (Supplementary Table 2 ) and VIC-conjugated probe for ActB (employed to normalize gene expression) were used along with TaqMan Gene Expression Master Mix (Applied Biosystems, 4369016) to perform quantitative PCR on the ABI PRISM 7900HT Fast Real-Time PCR System (Applied Biosystem).
For analysis of mRNAs encoding different VEGF-A isoforms from whole retinas of Dll4 i EC/ EC and the corresponding control mice, Taqman primers and FAMconjugated probes for specific VEGF-A isoforms (Supplementary Table 2 ) were used as described above.
For each group at least five mice, unless otherwise stated, were analysed to obtain the relative expression differences.
Notch inhibition in MS1 cells.
Murine pancreatic endothelial MS1 (ATCC CRL-2279) cells were cultured according to the manufacturer's instruction. MS1 cells (4 × 10 5 ) were plated in a 6-well dish 16 h before DAPT (Merck Millipore, 565770; 10 µM final concentration) or the corresponding volume of dimethylsulfoxide was applied in the preconditioned culture medium. Cells were incubated for 3 h at 37 • C and further lysed in RLT plus lysis buffer (Qiagen, 1053393) supplemented with β-mercaptoethanol.
The MS1 cell line used in this study was neither authenticated nor tested for mycoplasma contamination, and is not listed in the database of commonly misidentified cell lines that is maintained by ICLAC and NCBI Biosample.
Chromatin immunoprecipitation (ChIP).
ChIP experiments were performed essentially as previously described 71 . Murine MS1 cells were fixed in 1% formaldehyde (FMA) for 10 min at room temperature in the culture medium and the reaction was blocked with 1/8 volume of 1 M glycine pH 8.0. Only in the case of the anti-RBPJ ChIPs, cells were first washed twice in PBS, fixed for 1 h at room temperature in 10 mM dimethyladipimate (DMA) in PBS, washed once in PBS and fixed for 30 min at room temperature in 1% FMA. For all ChIP experiments, cells were washed twice with PBS and resuspended in SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl pH 8.1). After 10 min of incubation on ice, the cell suspension was sonicated using a sonication device (Covaris System S220 AFA) and the lysate was centrifuged for 10 min at 18,000g at 4 • C. The chromatin was diluted with ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl pH 8.1, 167 mM NaCl) and pre-cleared with 30 µl ml −1 nProtein A Sepharose 4 Fast Flow ((GE Healthcare, 17-5280-01); pre-saturated with salmon sperm DNA (Invitrogen)) for 30 min at 4 • C. After centrifugation, 50 µl of chromatin was collected as input control and the rest of the chromatin was aliquoted and incubated overnight with the desired antibody (IgG, anti-RBPJ, anti-H3K4me1, anti-H3K4me3, anti-H3K9ac, anti-H3K9me3, anti-H3K27ac, anti-H3K27me3, anti-H3). Antibodies were immobilized with 40 µl Protein A Sepharose 4 Fast Flow (pre-saturated with salmon sperm DNA) for 1 h at 4 • C with shaking. Beads were washed with low-salt washing buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1, 150 mM NaCl), high-salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1, 500 mM NaCl), LiCl wash buffer (0.25M LiCl, 1% IGEPAL-CA630, 1 mM EDTA, 10 mM Tris-HCl pH 8.1) and TE buffer (10 mM Tris-HCl, 1 mM EDTA pH 8.0). Chromatin was eluted from beads with Elution Buffer (1% SDS, 0.1M NaHCO 3 ) and crosslinks were reverted at 65 • C overnight in the presence of 180 mM NaCl. Samples were treated with Proteinase K for 1 h at 45 • C and the DNA was purified by phenol/chloroform extraction. After precipitation overnight at −20 • C in the presence of 10 µg of yeast tRNA, 40 µg glycogen and 500 µl 2-propanol, the DNA was washed with 70% ethanol. The DNA was dried, dissolved in TE pH 8.0 and analysed by qPCR. qPCR reactions were assembled with Absolute QPCR ROX Mix (Thermo Scientific AB-1139), genespecific oligonucleotides and double-dye probes (see Supplementary Table 2 ) and finally analysed using the StepOnePlus Real-Time PCR System (Applied Biosystem). A region located on chromosome X (chrX:112357567+112357626) was used as a control.
Image acquisition, processing and statistical analysis. Dissection of retinas was done under the dissection microscope (Leica M165C, Leica). Overview pictures of retina samples were imaged using a fluorescence microscope (Leica MZ16 F, Leica) coupled to a digital camera (Hamamatsu C4742-95, Hamamatsu). Confocal image acquisition was performed using confocal microscope SP5 (Leica SP5, Leica) and TCS-SP8 (Leica TCS-SP8, Leica). Photoshop and Illustrator (Adobe) software were used for image processing in compliance with Nature Cell Biology's guidelines for digital images. Processing and quantification of vascular parameters was done using Volocity software (Improvision).
Retina vascular parameter analysis was mostly done as previously described 61 . For the quantification of retinal vessel progression overview images (×2.5) of IB4-stained retina vasculature were obtained. The ratio between the length of vessel progression (from optic disc to the edge of the angiogenic front) and the length of retina leaflet (from optic disc to the periphery) was calculated for each retina leaflet. The mean of all leaflet ratios was obtained per retina and compared between mutant and control groups.
For quantification of filopodia and sprouts, high-resolution confocal images (×40) of IB4-labelled retina vasculature were acquired. Three-four pictures on comparable front areas were imaged for each retina. The quantification of filopodia number in each picture was done by calculating the ratio of total number of filopodia counted per angiogenic front vessel length. The mean for each retina was obtained and compared between the mutant and control groups. The quantification of sprouts in each picture was done by calculating the ratio of total number of sprouts counted per angiogenic front line. The mean for each retina was obtained and compared between mutant and control groups.
For the quantification of branching points and EC area, generally four confocal images (×20) of the IB4-labelled capillary plexus (specifically, the area between an artery and a vein) excluding the angiogenic front were acquired for each retina. A capillary plexus field in which the quantification was further carried out was first defined and identically applied to all of the images acquired. The mean for each retina was obtained and compared between mutant and control groups.
For the quantification of proliferating EC nuclei, four high-resolution confocal images (×40) of IB4-, ERG-and EdU-labelled retinal vasculature were acquired between an artery and a vein for each retina. The total number of Erg + nuclei counted was divided by the EC area for each image acquired. The mean for each retina was obtained and compared between mutant and control groups. In addition, doublepositive EdU + Erg + EC nuclei were counted and the total number was divided by the EC area calculated for each acquired image. The mean for each retina was obtained and compared between mutant and control groups.
For the quantification of GFP + sprouts per angiogenic front area, lowermagnification confocal images (×10) of IB4-and GFP-stained retinal vessels were acquired for each retina leaflet. Using the Volocity quantification module, the angiogenic front was defined as a region of interest (ROI). ROIs were limited only to the sprouts and the first adjacent stalk cells. The ratio of GFP + area per angiogenic front IB4 + EC area was calculated for each retina leaflet and the mean per retina was compared between mutant and control groups.
For quantification of total GFP + EC area per total EC area, the same ×10 images were used. Using the Volocity quantification module, the ratio of total GFP + area per IB4 + EC area was calculated for each retina leaflet and the mean per retina was compared between mutant and control groups.
For the quantification of GFP + area per arterial EC area, a minimum of five samples per group were imaged and analysed. Using the Volocity quantification module, the arterial area was defined as a ROI. ROIs were limited only to the main arteries and first order arterial branches. Arteries in damaged areas or at the edge of the imaged region were excluded. The ratio of GFP + area per IB4 + arterial EC area was calculated for each retina leaflet and the mean per retina was compared between mutant and control groups.
Signal intensities of VEGF-A or ESM1 immunostainings were quantified using Adobe Photoshop software from four ×40 acquired confocal images per retina. IB4 + area and VEGF-A-or ESM1-immunostained areas were examined by pixel number. For vascular-specific expression, specifically stained area in IB4 + vasculature was selectively quantified. The mean per retina was obtained and compared between mutant and control groups.
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For quantification of GFP + NICD iOTC/OTC EC distribution between the periphery and the centre at 24 h, 48 h, 72 h or 96 h after Cre-induced recombination, ×20 confocal images were obtained for both peripheral and central retinal regions, which covered the entire retinal vasculature. The total number of GFP + nuclei per peripheral and central area was quantified for each retina. Furthermore, the GFP + nuclei from the peripheral area were counted according to their distribution in the leading front (defined as the area to the second branch in the plexus), capillary plexus or arteries extended in the front area. Similarly, the GFP + nuclei from the central area were counted according to their localization in the capillary plexus or arteries. The ratio of peripheral or central GFP + nuclei per total GFP + nuclei was calculated for individual retina and averaged for each time point analysed.
For each group at least five retinas of mutant and corresponding littermate control pups from three litters injected with tamoxifen or 4-OHT, unless otherwise indicated, were quantified for vascular parameters for statistical analysis.
All images shown in the figures are maximum intensity projections and are representative of at least three mice analysed for each genotype unless stated otherwise.
Statistics and reproducibility. Statistical analysis was performed using Microsoft Excel with StatPlus software for data analysis or Graphpad Prism 7 software. All data are presented as mean ± s.e.m. or mean ± s.d. (as indicated in the figure legends). Unpaired two-tailed Student's t-tests with Welch's correction (variances between groups were not equal) were used to determine statistical significance between two groups. For analysis of the statistical significance of differences between more than two groups, we performed one-way and two-way ANOVA with Tukey's multiple comparison tests to assess statistical significance with a 95% confidence interval. P < 0.05 was considered significant unless stated otherwise. No statistical method was used to predetermine sample size. Sample number was chosen according to the previous experiments. Reproducibility was ensured by several independent experiments. The experiments were not randomized and the investigators were not blinded during experiments and outcome assessment. No animals were excluded from analysis. RT-qPCR results obtained from sorted retinal ECs, in which one of the technical duplicates failed to amplify, were excluded from the analysis. Unless otherwise indicated, results are based on three or more independent experiments to guarantee reproducibility of findings.
Data availability. Source data for Fig. 5b,c and Supplementary Fig. 5a have been provided as Supplementary Table 3 . All other data supporting the findings of this study are available from the corresponding authors on reasonable request.
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In the format provided by the authors and unedited. Supplementary Figure 3 Role of endothelial CXCR4 in retinal angiogenesis a, Representative overview confocal images showing IB4-labelled Cxcr4 i∆EC/∆EC and Cxcr4 i∆EC/KO retinas together with the corresponding controls. Circles indicate vessel outgrowth in the control. b, Combined ERG (EC nuclei; red), IB4 (green) and EdU (blue) staining shows reduced ERG+ EdU+ EC numbers in Cxcr4 i∆EC/∆EC retinal vessels compared to littermate control. EdU pulselabelling was done 2h prior to analysis. c, Representative confocal images of CXCR4 (red/white) and IB4 (green) stained Cxcr4 i∆EC/KO and control retinas. Arrowheads mark sprouts at the angiogenic front. d, ESM1 (white) and IB4 (green) staining of Cxcr4 i∆EC/∆EC and control retinas. ESM1 expression is not overtly changed. e, Quantitative analysis of EC proliferation for Cxcr4 i∆EC/∆EC and control littermates (n=7 control and 8 Cxcr4 i∆EC/∆EC retinas from two independent tamoxifen injections). Graphs indicate reduction of Cxcr4 i∆EC/ ∆EC ERG+ EdU+ cells per EC area at the angiogenic front relative to control, while the number of ERG+ cells was not significantly changed because of the impaired outgrowth. Data represent mean ± s.e.m. P values, two-tailed unpaired t-test. f, Quantitative analysis of vascular parameters for Cxcr4 i∆EC/KO , Cxcr4 KO/+ and control retinas: retinal vessel progression, EC area, branching points (n=7 control, 10 Cxcr4 KO/+ and 6 Cxcr4 i∆EC/KO retinas), and sprouts (n=5 control and 6 Cxcr4 i∆EC/KO retinas). Note absence of significant differences between Cxcr4 KO/+ heterozygotes and controls. Data represent mean ± s.e.m. P values, two-tailed unpaired t-test and one-way ANOVA with Tukey's multiple comparison post-hoc test. g, RT-qPCR analysis for Cxcr4 (n=6 control and 7 Cxcr4 i∆EC/∆EC mice), Vegfa (n=6 control and 12 Cxcr4 i∆EC/∆EC mice) and Esm1 (n=5 control and 7 Cxcr4 i∆EC/∆EC mice) in sorted Cxcr4 i∆EC/∆EC and control retinal ECs. Data represent mean ± s.e.m. P values, two-tailed unpaired t-test. h, RT-qPCR expression analysis of the Notch pathway components Dll4 (n=7 control and 9 Cxcr4 i∆EC/∆EC mice), Jag1 (n=8 control and 12 Cxcr4 i∆EC/∆EC mice) Hey1 (n=4 control and 10 Cxcr4 i∆EC/∆EC mice) and Hes1 (n=5 control and 12 Cxcr4 i∆EC/∆EC mice) in sorted Cxcr4 i∆EC/∆EC and control retinal ECs. Data represent mean ± s.e.m. P values, two-tailed unpaired t-test. 
